Johnson & Johnson JNJ
NYSE JNJ
$270.24 +2.87 (+1.07%)
At close: Aug 21, 2026 · 4:00 PM EDT

Johnson & Johnson (JNJ) Change in Acquisitions & Divestments (2009 - 2026)

Johnson & Johnson (JNJ) posted Change in Acquisitions & Divestments of $159.0 million for Q2 2026, down 23.92% sequentially from $209.0 million in Q1 2026, and down 78.37% YoY from $735.0 million in Q2 2025.

Johnson & Johnson (JNJ) Change in Acquisitions & Divestments (2009 - 2026) Analysis & Trends

Johnson & Johnson has reported Change in Acquisitions & Divestments for 18 years, with the latest figure at $159.0 million in Q2 2026.

  • Quarterly Change in Acquisitions & Divestments fell 78.37% year-over-year to $159.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.1 billion (down 37.04% YoY) and the FY2025 annual result came in at $1.7 billion, down 32.53% from the prior year.
  • Change in Acquisitions & Divestments retreated to $159.0 million in Q2 2026 per JNJ's latest filing, from $209.0 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $24.8 billion in Q1 2023 and troughed at $159.0 million in Q2 2026.
  • A 5-year average of $3.4 billion and a median of $731.0 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
  • The sharpest annual moves came in 2023 and 2024: Change in Acquisitions & Divestments increased 23.21% in 2023, then tumbled 91.95% in 2024.
  • Over 5 years, Change in Acquisitions & Divestments stood at $6.3 billion in 2022, then sank by 42.84% to $3.6 billion in 2023, then sank by 91.95% to $290.0 million in 2024, then fell by 24.48% to $219.0 million in 2025, then fell by 27.4% to $159.0 million in 2026.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $159.0 million, $209.0 million, and $219.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn
10 Sanofi 55.07 Bn 47.69 Bn 10.79 Bn

Historic Data

Download Data
DateValue
Jun 28, 2026 159.00 Mn
Jun 28, 2026 159.00 Mn
Mar 29, 2026 209.00 Mn
Mar 29, 2026 209.00 Mn
Dec 28, 2025 219.00 Mn
Dec 28, 2025 219.00 Mn
Sep 28, 2025 489.00 Mn
Sep 28, 2025 489.00 Mn
Jun 29, 2025 735.00 Mn
Jun 29, 2025 735.00 Mn
Mar 30, 2025 218.00 Mn
Mar 30, 2025 218.00 Mn
Dec 29, 2024 290.00 Mn
Dec 29, 2024 290.00 Mn
Sep 29, 2024 466.00 Mn
Sep 29, 2024 466.00 Mn
Jun 30, 2024 727.00 Mn
Jun 30, 2024 727.00 Mn
Mar 31, 2024 979.00 Mn
Mar 31, 2024 979.00 Mn